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Abstract
Neuronal cells are the main fundamental anatomic unit of the system. Nerve injuries are 
generally divided into three categories as neuropraxia, axonotmesis and neurotmesis. 
Neurotmesis is the most severe form. Schwann cells are activated within 24 hours of 
the injury and the healing cascade continued with the cells, which are stimulated by 
Schwann cells. And neurotrophic factors like nerve growth factor (NGF) have a crucial 
role in regeneration and degeneration processes. Additionally, Schwann cells upregu-
late the expression of some proteins, such as fibronectin, which are crucial for axonal 
regeneration. All this information about nerve healing sheds light on treatment stud-
ies. Iatrogenic nerve injury has an important place in peripheral nerve injury. Causes 
may be direct surgical damage, wrong intraoperative patient positioning, anaesthesia-
related reasons or limb tourniquets. Typical symptoms are motor or sensory deficits 
such as paraesthesia, weakness, paralysis and pain. Many of the traumatic nerve injuries 
require surgical repair. Direct nerve repair and autologous nerve grafts are still gold-
standard treatment options. Additionally, nerve conduits are very successful to provide 
an ideal peripheral support for neuronal recovery but are still insufficient. In recent years, 
research efforts have focused on the neurotrophic factors and cell-based therapies to per-
form better microenvironment for neuronal healing.
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1. Introduction
An injury to a nerve can result in a problem with the muscle innervation or in a loss of sensa-
tion. In some people, it can also cause pain. The type of nerve injury will determine the type of 
treatment that will be needed. Peripheral nerve injuries (PNIs) affect all age groups and have 
many causes like trauma and medical disorders. The majority of the peripheral nerve injuries 
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(PNI) occur in the upper extremity and are secondary to trauma [1]. Typical symptoms are 
motor or sensory deficits such as paraesthesia, weakness, paralysis and pain [2]. Many of the 
traumatic nerve injuries require surgical repair. The primary goal of the repair is to achieve 
the reinnervation of the target organs, but the therapeutic options which are used at present 
cannot achieve perfect sensory and motor recovery in all cases. In this chapter, the patho-
physiology and mechanisms of nerve injuries, the traumatic nerve injuries, especially the iat-
rogenic forms, and therapeutic options for the peripheral nerve injuries will be discussed.
2. Peripheral nerve anatomy
Peripheral nervous system consists of neuronal cells, glial cells and stromal cells. Neuronal 
cells are the main fundamental anatomic unit of the system. Neurons conduct electrical 
signals between central nervous system and other parts of the body. Afferent neurons 
carry information from the body to the brain, and efferent neurons carry signals from 
central nervous system to target organs. Each neuron consists of a cell body, dendrites 
and an axon. Transportation of the action potential is from cell body through the exten-
sion of the body called axons. Cell body is the source of nutritional elements and neu-
rotransmitters. Nerve fibres are categorized into three groups based on their functions 
(motor, sensory and autonomic neurons) and into two groups according to structural 
characteristics (myelinated and unmyelinated). Myelin is a critical molecule for conduc-
tion of action potential, which is composed of 30% proteins and 70% lipids. Schwann 
cells (SCs) constitute the major neuroglial component of the peripheral nervous system 
and surround axons at regular intervals forming the myelin. And there are unmyelinated 
intersegmental areas known as Ranvier nodes. Ranvier node is enriched with voltage-
sensitive sodium channels and generates ionic impulses only at the node. Owing to this 
structure, action potential jumps from one node to the next along the length of the axon 
and saltatory conduction occurs. This process results in faster conduction of the action 
potential in myelinated nerves rather than unmyelinated nerves [3, 4].
Connective support of the neuron consists of three laminary structures including endoneu-
rium, perineurium, epineurium and mesoneurium. The deepest structural layer nearest to 
the axon is endoneurium, which is composed of collagen fibres. Perineurium surrounds mul-
tiple nerve fibres and their endoneuriums. Perineurium is composed of collagen fibres and 
perineural cells, which provide a protective barrier between the nerve and its blood supply. 
The entry of large proteins, toxins, antigens and infectious agents is prevented by that bar-
rier (blood-nerve barrier) [3]. Perineurium has a major role in maintaining the integrity and 
providing tensile strength and elasticity of the nerve [5]. The external layer is the epineurium, 
which consists of two components. Interfascicular epineurium surrounds each nerve fascicle, 
and the extrafascicular epineurium invests the entire nerve trunk and clinches the blood ves-
sels to the nerve [4]. The epineurium is a quite strong layer and resists to compression inju-
ries with its collagen fibres and lipid globules. Besides, epineurium is known as the most 
abundant type of connective tissue of the nerve. Eighty-eight per cent of the sciatic nerve is 
composed of epineurium at the gluteal level [6]. The outermost tissue around the nerve trunk 
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is mesoneurium. Mesoneurium harbours anastomoses between veins and arterioles of the 
nerve. Mesoneurium limits the frictional forces during movement of the nerve against closed 
local structures [7].
3. Grading nerve injury
The first approach to the nerve injury is grading because that defines the severity of the injury 
and success of the repair. The most widely accepted grading system, which was defined by 
Seddon and Sunderland, is according to the microscopic changes secondary to the injury [6, 8].
Seddon divided nerve injuries into three categories as neuropraxia, axonotmesis and neu-
rotmesis. The mildest form of nerve injury is neuropraxia, which is characterized by focal 
demyelination without damage to nerve continuity. This kind of injury does not cause dis-
tal degeneration. Neuropraxia typically occurs after compression or traction of the nerve. 
The conduction velocity is decreased, but the damage is transient [9]. The complete recovery 
time of the injury varies from 1 week to 6 months [10]. Axonotmesis is the damage to the 
axons with focal demyelination where connective tissues (perineurium and epineurium) of 
the nerve are preserved. Distal axon and myelin degeneration causes complete denervation. 
Although the motor and sensory function recovery is not as fast as in neuropraxia, preserva-
tion of the supportive tissue makes recovery perfect in axonotmesis. The most severe form of 
the nerve injury is neurotmesis, which is defined as full anatomical and physiological tran-
section of the nerve. All functional components are damaged, and recovery without surgical 
repair is impossible [11].
Sunderland divided nerve injuries into five categories mostly according to supportive tissue 
damage [6]. First-degree injury is equivalent to neuropraxia defined as partial disruption in 
conduction. Second-degree injury is equivalent to axonotmesis. In the third-degree injury, peri-
neurium is left intact, but endoneurium and axon are disrupted. The functional recovery of the 
nerve depends on the extent of the injury. In the fourth-degree injury, epineurium is the only 
structure that remains intact. Surgical repair is required for recovery. The fifth-degree injury 
defines complete transaction of the nerve, and as in neurotmesis, surgical repair is necessary [4].
4. Pathophysiological changes after nerve injury
The injury to the neuronal tissue does not result in mitosis or cell proliferation like other tissues 
of the human body. First-degree injuries result in mild or no pathological changes. Only decre-
ment of conduction velocity is observed, and none of the regeneration or degeneration pro-
cesses are activated. However, in the second-degree injury, a unique pathophysiological change 
defined as Wallerian degeneration occurs in the neural tissue which is not observed in any 
other tissues [12]. In Wallerian degeneration, a calcium-mediated process results in anterograde 
degeneration distal to the injury site. Wallerian degeneration ensues 24–48 hours after the injury 
with fragmentation of distal axons and myelin is formed histologically [13]. Disorganization of 
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neurotubules and neurofilaments causes irregular axonal margins. Structural axonal durability 
is lost 48–96 hours after injury and conduction of impulses ceases. Myelin disintegration lags 
slightly behind that of axons but is well advanced by 36–48 hours [11].
Schwann cells are activated within 24 hours of injury. Their initial role is phagocytosis of the 
axonal and myelin debris. Macrophages migrate to the injury site and stimulate proliferation 
of Schwann cells and fibroblasts. Schwann cells and macrophages work together to clean up 
the injury site which may take 1 week to several months. The other significant role of Schwann 
cells is to complete the cleaned endoneurial tubes in organized longitudinal columns defined 
as Bungner’s bands. Bungner’s bands are important guides for sprouting axons during rein-
nervation [11, 14, 15].
The third-degree injury (intrafascicular injury) involves retraction of the severed nerve fibre 
ends due to elastic endoneurium. Local trauma leads to a significant inflammatory response. 
Fibroblast proliferation aggravates the process, and a dense interfascicular scar forms. This 
kind of injury impairs axonal regeneration, and endoneurial tubes remain denervated. If the 
endoneurial tube does not receive a regenerating axon, progressive fibrosis eventually obliter-
ates it. In the fourth- and fifth-degree injuries, activated Schwann cells and fibroblasts cause 
vigorous cellular proliferation. Local vascular trauma leads to macrophage accumulation. In 
these injuries, the nerve ends become an irregular mass of Schwann cells, fibroblasts, macro-
phages and collagen fibres. Regenerating axons reach that disorganized proximal stump and 
encounter a rough barrier that impedes further growth [11].
Disconnection of cell bodies and axons activates programmed cell death pathway within 6 
hours of the injury in a process called chromatolysis [9, 15].
Neurotrophic factors have a crucial role in regeneration and degeneration processes. 
Macrophages that migrate to the injury site express interleukin-1 (IL-1). IL-1 stimulates nerve 
growth factor (NGF) production by Schwann cells. NGF is very important for axonal regener-
ation process and myelin formation [16]. Additionally, Schwann cells upregulate the expres-
sion of fibronectin, laminin and neurotrophins, which are crucial for axonal regeneration [11]. 
All of these factors are not enough for recovery of transected nerves. If the surgical repair fails, 
denervation of the distal end leads to lack of impulse conduction followed by loss of motor 
end plates and muscle fibrosis [17].
5. Mechanisms of peripheral nerve injury
There are various mechanisms that lead to peripheral nerve injury. All types of traumatic 
injury can have an iatrogenic component. Direct nerve damage is one of the mechanisms 
that may occur during surgery or accidentally secondary to an external trauma. These iat-
rogenic injuries may be provoked by knives, propellers and scalpels used in surgery or a 
needle trauma secondary to the anaesthesia technique. Traction injuries may occur during 
surgery by surgical retractors or wrong positioning of the limbs. Compression injury occurs 
secondary to wrong positioning of the limbs, poor padding of the body surfaces or use of 
surgical tourniquets. The pathophysiological mechanisms of compression injury involve both 
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mechanical compression damage and ischemic damage. Ischemic injury may be caused by 
surgical tourniquets, prolonged immobility, haematoma surrounding a nerve or vasocon-
strictor agents. Injection of neurotoxic drugs is another iatrogenic cause of nerve injury. An 
additional mechanism involved in peripheral nerve injury is double crush syndrome. Patients 
who have medical comorbidities (e.g., diabetes mellitus, rheumatoid arthritis) associated with 
peripheral neuropathy have more sensitive nerves and are more susceptible to a secondary 
damage like compression or laceration. A minor injury may cause permanent nerve injury in 
these patients. Patients with features such as diabetes mellitus, obesity, peripheral vascular 
disease, arthritis, alcohol usage, tobacco usage, advanced age, circulatory failure, extreme 
weakness are more likely to have nerve damage in the perioperative period [18–30].
There are also other risk factors which are independent from patients. Neurosurgery, car-
diac surgery, gastrointestinal surgery and orthopaedic surgery are associated with a higher 
incidence of peripheral nerve injury. Perioperative risk factors include hypovolemia, hypo-
tension, hypoxia, electrolyte disturbances, hypothermia, length of surgery (>2–4 hours) and 
patient positioning [19, 21, 31–35]. General anaesthesia and neuraxial blockage have a risk 
for peripheral nerve injury because they limit patients' own position changes as compared to 
mildly sedated patients.
6. Causes of iatrogenic nerve injury
In one study, 17.4% of the traumatic nerve injury cases (n = 722) surgically treated in a tertiary 
care service were iatrogenic in origin. And 94% of them occurred during a previous opera-
tion [36]. In an extensive retrospective study spanning a period of 10 years, the frequency of 
perioperative peripheral nerve injuries was 0.03% [37]. When operated nerves were examined 
individually based on surgical specialty, 25% of the operated sciatic nerve injuries, 50% of the 
operated femoral nerve injuries and 93% of the operated accessory nerve injuries were found 
to be caused by iatrogenic injuries [38–40].
Iatrogenic nerve injury may be associated with operational or nonoperational factors. Needle 
injections and external compressions are common nonoperational causes. Operational factors 
may be directly related to surgery or may involve wrong patient positioning. Direct intraoperative 
injury mechanisms include cutting, crushing, tying off, penetrating, twisting by screws, stretching 
by retractors, grabbing or squeezing by repositioned bone, coagulating with cautery or bipolar 
forceps, burning by cement or excision of the target pathology. It was reported that 94% of the 
iatrogenic peripheral nerve injury operations were caused by direct surgical damage [36, 41–43].
Nerves cannot always be clearly visualized in the operative field. There are reports that they 
have been mistakenly recognized as a tendon or vessel [44–47]. And sometimes nerves may be 
removed during nerve sheath tumour or lymph node excision (accessory nerve may be dam-
aged during lymph node dissection from posterior triangle of the neck).
Nerve sheath tumours are another surgical risk factor for nerve injuries because they are 
rarely truly recognized and approached. They may be diagnosed as an unspecified lump, 
undetected tumour or ganglion, so the surgical interventions may result in disappointment. 
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Nerve sheath tumours are mostly of benign nature (schwannoma or neurofibroma), and 
appropriate surgical interventions are able to correct neurological deficits [48].
In order to avoid such outcomes, surgeons must have extensive anatomic knowledge about 
peripheral nerves and be experienced in specialized surgical intervention.
6.1. High-risk surgical procedures
In addition to all other external factors, certain surgeries carry a high risk for peripheral 
nerve injury. Common procedures that may cause nerve injury are osteosynthesis, osteot-
omy, arthrodesis, lymph node biopsies from the posterior triangle of the neck, carpal tunnel 
release, Baker’s cyst excision, varicose vein surgery and inguinal hernia repair [41].
A study reported that the most common surgical interventions associated with peripheral 
nerve injury are as follows in decreasing order: 45% major procedures (orthopaedic proce-
dures, abdominal surgery and trauma), 27% minor procedures (lymph node surgery and vari-
cose vein surgery), 15% neurosurgical interventions (carpal tunnel operations and tenolysis), 
and 4% non-surgical interventions (arterial or venous puncture and plaster cast) [36, 41].
6.2. Anaesthesia and peripheral nerve injury
Anaesthesia has a role in the emergence of perioperative peripheral nerve injury. Both gen-
eral and regional anaesthesia may potentially cause peripheral nerve injury with different 
mechanisms including compression, stretch, direct nerve trauma and local chemical toxicity 
[49]. An extensive retrospective review reported the incidence of perioperative PNI at 0.03%. 
The same review demonstrated that general anaesthesia and epidural anaesthesia have 
associations with nerve injury, but peripheral and spinal nerve blocks do not [37]. The ulnar 
nerve is the most commonly compromised nerve under anaesthesia [50]. Predisposing fac-
tors that make patients more susceptible to nerve injury are diabetes mellitus, hyperten-
sion, tobacco use, arthritis, obesity and low body weight [28, 37]. Except for compression 
injuries secondary to improper patient positioning, direct needle trauma may be the main 
cause of the anaesthesia-related peripheral nerve injury. There are various risk factors that 
affect the risk of nerve trauma with regional anaesthesia. Needle may damage the nerve 
fascicles directly, and damaged nerve vessels and existing extraneural or intraneural hae-
matoma may compromise nerve fascicles [51]. Injecting the local anaesthetic into a fascicle 
is the main source of peripheral nerve block-related nerve injury. Intrafascicular injection 
traumatizes the nerve, damages perineurium and results in the loss of protective environ-
ment within the fascicle [37, 51–53]. Epinephrine when combined with local anaesthetics 
tends to cause local vasoconstriction, but its role in causing nerve injury is still controver-
sial [54]. High-pressure local anaesthetic injection may damage neuronal microvasculature 
and cause neural ischemia [55]. Both neuraxial block and peripheral nerve blocks’ needle 
type is associated with neuronal injury risk. Nerve puncture with pencil-point or Tuohy 
needles causes a similarly high degree of injury [56]. Human studies could not demon-
strate the difference between neurostimulation-guided or ultrasound-guided nerve blocks 
in terms of nerve injury [51].
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Fortunately, complications of neuraxial blocks are rare. A large-scale research study reported 
that the incidence of neuraxial complications is 0.0075%, and 67% of them results in perma-
nent injury. The most common complications are spinal hematoma, cauda equina syndrome, 
purulent meningitis and epidural abscess. Studies mentioned that the risk of spinal haema-
toma is higher with epidural anaesthesia compared to spinal anaesthesia [57]. The risk is 
higher in patients who have coagulation abnormalities, advanced age, female gender, concur-
rent spinal stenosis or preexisting neurological diseases [58].
Improper positioning is another cause of anaesthesia-related perioperative peripheral nerve 
injury. Wrong patient positioning increases the compression pressure on nerves which are 
superficial or in close proximity to a bone. For example, the ulnar nerve is a superficial nerve 
which is in the vicinity of the medial epicondyle of the humerus, or the peroneal nerve is near 
the fibular neck. Additionally, excessive tractions of the nerves may be another injury mecha-
nism (excessive traction of the shoulder causes brachial plexus injury). Anaesthesiologists 
should be aware of the body position and its association with nerve injury (e.g., lithotomy 
and femoral nerve injury, lateral decubitus position and peroneal nerve injury, taping the 
shoulders and brachial plexus injury) [41]. The American Society of Anaesthesiologists pub-
lished a practice guideline for prevention of positioning-related peripheral nerve injury. The 
guideline recommends careful positioning of the patient, protective padding, padded arm 
boards and avoidance of contact with hard surfaces. Specifically, the guideline advised that 
arm abduction should be limited to <90° in the supine position to protect brachial plexus, neu-
tral forearm positioning or supination of the hand should be done with padding in the supine 
position to protect ulnar and median nerves, flexion of the elbow should be limited to <90°, 
appropriate padding should be applied in lithotomy in lateral and prone positioning, and hip 
flexion should be <120° in lithotomy positioning [59].
6.3. Tourniquet-related nerve injury (TRNI)
Despite its rare but devastating side effects, pneumatic surgical tourniquets are widely used in 
orthopaedic and plastic surgery because bloodless operative site is very important for optimum 
surgery. Pathophysiological mechanisms of the TRNI include mechanical compression and 
neural ischemia [60]. Mechanical compression causes microvascular congestion, inadequate 
perfusion, axonal degeneration and transient loss of innervation function [61]. These effects 
usually start within 2–3 hours. Even when the insufflation pressure is appropriate or tourniquet 
time is short, the potential for nerve injury still persists [62]. Fortunately, when standard recom-
mendations are followed, major neurological deficit is rare. The incidence of permanent injury 
is 0.032% [63]. If the mechanical stress is the major pathological factor in TRNI, it is recom-
mended that the placement of the tourniquet be as proximal as possible to the limb to enlarge 
the limb circumference with muscle mass with the aim to protect the nerves [64].
6.4. Regions with higher risk of nerve injury
In some body regions, nerves lay superficial and have close proximity with hard tissue. 
In these superficial regions, nerves have a narrow diameter that makes them more sus-
ceptible to the injury. These sites include the wrist (ulnar nerve), posterior triangle of the 
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neck (spinal accessory nerve (SAN)), posterior of the knee and popliteal fossa, fibular head 
(peroneal nerve), elbow and groin (ilioinguinal, iliohypogastric nerve) [8].
7. Peripheral nerves and clinical presentations of injuries
Based on the results of a large clinical experience report, the median nerve is the most com-
monly injured nerve among the iatrogenic nerve injuries. It is followed by the accessory 
nerve, radial nerve, common peroneal nerve (CPN), ulnar nerve and femoral nerve [41]. The 
diagnosis of iatrogenic nerve injury is easy. An asymptomatic patient starts to complain about 
neurological symptoms after a surgical intervention. Neurological symptoms may include 
sensory deficits or motor movement limitations. Sensory symptoms may include anaesthesia, 
paraesthesia, hypoesthesia, hyperesthesia and pain. Motor limitations may include paresis 
and paralysis. Autonomic dysfunction or neuropathic pain may be observed depending on 
the type of nerve and the injury process [49].
7.1. Lingual and inferior alveolar nerves
The lingual nerve is a sensory nerve, the inferior alveolar nerve is both sensory and motor, and 
two of them are branches of the mandibular nerve. These nerves are mostly injured during oro-
dental practices such as exodontic and endodontic procedures, dental implants and injection, 
and osteotomy. Injury symptoms are mostly similar to those mentioned above. Paraesthesia is 
a common symptom experienced by patients with these nerves injuries. The common cause of 
iatrogenic paraesthesia is extraction of third molars and dental injections. Twenty-five per cent 
of patients with iatrogenic paraesthesia suffer from permanent conditions and 75% regain nor-
mal sensation spontaneously without further treatment within 6–8 weeks [65, 66]. Spontaneous 
recovery may be prolonged up to 24 months. Microsurgery may be indicated in the following 
cases: confirmed transection of a nerve, total anaesthesia of the affected area 2 months after the 
trauma, lack of protective reflexes (on biting or burning of the tongue or lower lip) 2 months 
after trauma, dysaesthesia. Considerable functional improvement after surgery may be seen, 
but regaining normal sensation is not always possible [67].
7.2. Laryngeal nerves
The internal branch of the superior laryngeal nerve (IBSLN) provides general sensation for the 
tissue superior to the vocal cords. The external branch of the superior laryngeal nerve (EBSLN) 
innervates cricothyroid muscle and contributes to innervation of the pharyngeal plexus. The 
ESBLN is closely related to the superior thyroid vascular pedicle, and this anatomic relationship 
makes the nerve vulnerable to iatrogenic injuries. The recurrent laryngeal nerve (RLN) supplies 
four intrinsic muscles of the larynx except cricothyroid muscles and supplies the mucosa of vocal 
cords and subglottis. Although controversy still exists, exploration and dissection of the nerve are 
still recommended to avoid nerve injury during surgery. Thus, surgeons should identify some 
landmarks (inferior thyroid artery, tracheoesophageal nerve, Berry's ligament, Zuckerkandl's 
tubercle) which are closely related to the RLN to help protect the nerve from injury [68].
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Iatrogenic laryngeal nerve injury is mostly seen after anterior neck surgery (thyroid, parathy-
roid, anterior cervical spine surgeries, carotid endarterectomy). While advanced neurophysio-
logical monitoring techniques are performed during anterior neck surgery, clear visualization 
of the nerve during surgery is still more important to prevent nerve injury [69]. Symptoms 
of laryngeal nerve injury are difficulty in speaking, difficulty in swallowing, hoarseness and 
breathing problems (if the injury is bilateral) [68]. Laryngeal electromyography (EMG) has 
been the gold standard in the diagnosis of laryngeal nerve injuries. Iatrogenic RLN injury was 
found in 0.3–13.2% of the cases, and superior laryngeal nerve (SLN) injury occurred in less 
than 5% of the cases. Transient vocal cord palsy recovers within 6 months. Permanent vocal 
cord palsy, which is not recovering within 1 year, occurs in 0.4 and 2.8% of the cases [70–76].
The treatment of RLN injury includes medicines (neurotrophic agents, glucocorticoids or 
vasodilators), ultrashort wave therapy, voice training, vocal cord injections and reinnervation 
methods (decompression, end-to-end anastomosis, implantation of an ansa cervicalis nerve-
muscle pedicle). Recent treatment methods include thyroplasty, laser arytenoidectomy and 
cordectomy. The recovery success of the RLN depends on early diagnosis and early explora-
tion of the nerve [77–79].
The treatment of SLN injury includes voice therapy, type 1 or 4 thyroplasty and reinnervation 
using nerve muscle pedicle technique. There are no studies which extensively investigated 
the success of these therapeutic methods for SLN injury [80–83].
7.3. Facial nerve
Published facial nerve injury rates in oral surgical procedures vary from 2 to 25% and 0.6 to 
3.7% in primary tympanomastoidectomy. Secondary tympanomastoidectomy procedures 
doubled the risk of iatrogenic facial nerve injury (IFNI) (4–10%). In an epidemiologic report, 
oral maxillofacial surgery was the most common procedure that caused iatrogenic facial nerve 
injury. Temporomandibular joint reconstruction, mastoidectomy, parotidectomy and rhytidec-
tomy are the most risky procedures in terms of IFNI. Hemifacial paralysis is the most prevalent 
pattern of IFNI. When IFNI is diagnosed in a patient, he/she must be referred for facial nerve 
exploration immediately. Reconstruction should be performed within 4–6 months after sur-
gery to avoid severe atrophy of the mimetic muscles that occurs 12 months after denervation. 
Currently, no medical treatment exists for facial nerve injury. Systemic corticosteroids have 
minimal contribution to the recovery, and the mainstay of treatment is surgery. Surgical options 
include direct repair, cable nerve grafting and nerve substitution techniques. Residual weakness 
and synkinesis are common results of facial nerve repair. Common factors restricting functional 
recovery include older age, long grafts and extended delay between injury and repair [84–89].
7.4. Spinal accessory nerve
Cervical lymph node biopsy is the most common cause of iatrogenic spinal accessory nerve 
(SAN) injury, and the incidence after this procedure varies between 3 and 10%. SAN injury 
results in the loss of trapezius muscle motor function and weakness of the shoulder abduc-
tion, dropping of the shoulder, winging scapula and shoulder pain. Although SAN is a motor 
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nerve, patients often describe a sharp, electric shock pain during the procedure. Spontaneous 
recovery of SAN injury is very rare. If the lesion is left untreated, pain or functional deficit 
will occur in 60–90% of patients. The surgical repair procedures include end-to-end anasto-
mosis and nerve grafting. Early reconstruction surgery (within 3–6 months of injury) is rec-
ommended to avoid permanent functional deficit of the trapezius muscle. However, positive 
functional results can still be expected within 9 months of the injury since the distance to the 
target muscle is short [40, 89–92].
7.5. Brachial plexus
The anatomical features of the brachial plexus make it susceptible to iatrogenic injuries. 
Brachial plexus is superficial, lies between mobile bones and has a limited range of movement 
between the clavicle and the first rib. Iatrogenic injuries may be induced by compression, 
stretching or direct damage. Median sternotomy during cardiac surgery, lateral decubitus 
positioning, shoulder surgery, arm abduction and shoulder displacement are the iatrogenic 
causes of the injury. Motor dysfunction is the major clinical presentation that depends on 
the injury level. Surgical treatment options include neurolysis, nerve suture, nerve grafting 
and neurotization. Timing of surgery differs according to the injury type. Laceration injuries 
should be explored acutely, blunt injury reconstruction may be performed within 2–3 weeks 
of the injury and closed traction injury is operated within 4–5 months of the surgery [49].
7.6. Median nerve
As demonstrated in a comprehensive research study, median nerve is the nerve most com-
monly susceptible to iatrogenic nerve injury [42]. Median nerve is mostly harmed during 
carpal tunnel release procedures. Surgeon’s knowledge on skin landmarks may diminish the 
nerve damage. Median nerve injury presents with paraesthesia in the palmar side of the fin-
gers, weakness of abduction, opposition of the thumb and forearm being kept in supination. 
Near the motor deficit, patient may complain about electric-like shooting pain. Early explora-
tion and treatment are recommended before chronic pain syndrome is manifested [49].
7.7. Ulnar nerve
Ulnar nerve injury is the most common perioperative peripheral nerve injury because the 
ulnar nerve is superficial and in close proximity to the medial epicondyle of the humerus. 
Subclinic neuropathy is the most common presentation. Tingling, numbness along the little 
finger, weakness of abduction and abduction of the fingers are usual clinical presentations [49].
7.8. Radial nerve
Radial nerve lies along the spiral groove of the humerus, and this location is the most injured 
site of the nerve by dislocated humeral fracture. Open reduction and fixation of the fracture 
may cause iatrogenic nerve injury. Kirschner wire placement for radial fractures can pen-
etrate the nerve. Thus, mini-incisions for surgical procedures rather than percutaneous pro-
cedures are preferable to protect the nerve. There are numerous treatment options for radial 
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nerve repair. None of them has proven better outcomes than others. However, radial nerve 
has a perfect recovery profile after reconstruction [49].
7.9. Phrenic nerve
The phrenic nerve supplies diaphragm that originates from cervical nerve roots and descends 
through the thorax. Left phrenic nerve lies within the pericardium. The phrenic nerve paraly-
sis occurs mostly after cardiothoracic surgery with an incidence of 1.4–7%. In addition to 
trauma, pericardial crushed ice placement is another cause of iatrogenic nerve injury in car-
diac surgery. Elevated hemidiaphragm, lower lobe atelectasis and poor respiratory effort are 
the clinical presentations of the paralysis. Cold injury and internal mammary artery dissec-
tion increase the risk of phrenic nerve injury. Even if it takes weeks and months, the prognosis 
of phrenic nerve injury is good. Most patients recover within 1 year eventually [93–95].
7.10. Inguinal nerves
The ilioinguinal, genitofemoral and iliohypogastric nerves are cut, coagulated, sutured or incor-
porated into a mesh during open and endoscopic inguinal hernia repairs. These nerves may 
also be injured during laparotomy. Inguinal nerve injury during hernia repair occurs in 0.5–2% 
of the procedures. Clinical presentation of these nerve injuries includes a sharp, burning pain 
radiating to the suprapubic area, labia or scrotum, paraesthesia over the same areas and pain 
relief after infiltration of a local anaesthetic. Symptoms are aggravated by stretching, coughing, 
sneezing and Valsalva manoeuvres. Pain is diminished in more than 90% of the patients after 
neurectomy and excision of the injured nerve [96–100].
7.11. Femoral nerve
Postoperative hematoma, cement extrusion, trauma from retractors, bone or prosthesis mal-
positioning and lithotomy position with extreme abduction of thighs are the main causes of 
iatrogenic femoral nerve injury. Deep pelvic surgery and abdominal surgeries are procedures 
that are most commonly implicated in iatrogenic femoral nerve injury. In these operations, 
the common risk factor is compression by retractor blades. Thin subcutaneous fat layer, surgi-
cal duration longer than four hours, poorly developed rectus muscle, narrow pelvis and self-
retaining retractors are the risk factors for femoral nerve compression. Clinical presentations 
of femoral nerve injury include loss of sensation at the front of the thigh, weak hip flexion and 
loss of knee extension. Although severe nerve injuries need long nerve grafts, femoral nerve 
reconstructions result in good functional recovery [101–103].
7.12. Sciatic nerve
Sciatic nerve injury manifests itself as paralysis of the hamstring muscle, foot drop and 
impaired sensation below the knee except medial regions. The lithotomy, frog leg and sitting 
positions cause perioperative nerve injury by stretching the nerve [49]. Sciatic nerve injuries 
are mostly reported as a complication of total hip arthroplasty with an incidence of 0.16–8%. 
Hip dysplasia, posterior approach, revision surgery (3.2%), limb lengthening, female gender 
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and younger age are the primary risk factors of nerve injury. The most common mechanisms 
include tension, direct trauma by retractors, compression by postoperative hematoma, direct 
lacerations and sutures. Sciatic nerve injury occurs in 1.7% of hip arthroscopies. Complete 
injuries without therapy cause 100% limb disability [104–108]. Results of operative treatments 
are mixed. A large series of sciatic nerve repairs reported that tibial division recovery is better 
than peroneal division, and outcomes at the thigh are better than at the buttock [101].
7.13. Common peroneal nerve
The common peroneal nerve (CPN) injury presents with loss of dorsiflexion and eversion of 
the foot (equinovarus deformity). Sensory impairment occurs in the anterolateral region of 
the leg. Iatrogenic injuries are related to high tibial osteotomies (HTO) (4.9%) and total knee 
arthroplasties (TKA) (0.3–9.5%). Revision surgeries, preoperative valgus deformity, rheuma-
toid arthritis, history of previous HTO, prolonged tourniquet time and history of laminectomy 
are the risk factors of perioperative CPN injury [109–113]. Lithotomy and lateral position are 
the nonsurgical perioperative risk factors for CPN injury which is associated with fibular 
head compression. Full recovery rates of partial nerve injury vary between 76 and 87%, and 
complete injury recovery is seen in 20–35% of the cases [101]. Surgical treatment is indicated 
if no evidence for recovery is observed.
8. Functional assessment and management of peripheral nerve injury
Clinical presentations of peripheral nerve injury usually include pain, dysaesthesia and partial 
or complete loss of motor and sensory functions. Evaluation of the injury starts with complete 
history and physical examination. Diagnosis is established through electrodiagnostic assess-
ment and radiological studies. Treatment options are performed according to the wound char-
acteristics at the appropriate timing in terms of the injury mechanism after all examinations.
Physical examination should involve detailed assessment of motor and sensory deficits. 
Moving and static two-point discrimination, sharp and dull discrimination, grading of grip 
and pinch strength should be tested and recorded preoperatively. Subsequent to these proce-
dures, peripheral tissues of the injury site (soft tissue, vascularization) should be examined. 
Tinel's sign over the course of the injured nerve will be positive. It refers to paraesthesia 
elicited by lightly tapping over the suspected location. Tinel's sign is elicited by regenerating 
axonal growth [114].
The timing of functional assessment according to the injury type is an important issue for 
diagnostic success. Optimum timing for electrodiagnostic studies varies between injury 
types. The formation of Wallerian degeneration is the main point of distinction of the neuro-
praxia, axonotmesis or neurotmesis. Initial electrodiagnostic studies 7–10 days after an acute 
injury may be helpful to localize the lesion and to distinguish conduction blocks from axo-
notmesis. Electrodiagnostic studies, which are performed 3–4 weeks after surgery, provide 
more information about the lesion because fibrillation potentials may not appear until this 
time [115]. Electrodiagnostic studies are mostly useful during intraoperative management 
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while checking an action potential distal to the injury. They are also useful to distinguish the 
intact fascicle and neuroma intraoperatively. Electrophysiological procedures have a critical 
role in monitoring recovery and determining neuronal reinnervation 2–4 months after nerve 
surgery [114].
Electromyography (EMG) demonstrates the electrical activity of a muscle and is useful for 
detecting injuries of efferent peripheral neuron and motor unit. Reduced number of functional 
axons after an injury causes EMG abnormalities. In neuropraxia, it demonstrates normal or 
decreased recruitment. However, following lesions causing axon loss, EMG demonstrates 
abnormal activity such as fibrillation and positive sharp waves. EMG may be normal immedi-
ately after axonotmesis and demonstrates abnormal activity after 10–14 days. The onset of the 
fibrillations depends on the length of the distal nerve stump. Fibrillation development with 
short stumps may take 10–14 days, and for longer stumps, it may take 21–30 days (e.g., ulnar-
innervated hand muscles in a brachial plexopathy) [115].
Nerve conduction studies (NCS) assess both motor and sensory functions of the nerve via a 
voltage stimulator. The evoked response is recorded from a surface electrode overlying the 
muscle (motor response) or nerve (sensory response). NCS is used initially to demonstrate the 
presence of conduction block [13]. In pure neuropraxic injuries, motor response failures occur 
immediately and conduction is detected to be normal distal to the lesion. Electrodiagnostically 
complete axonotmesis and complete neurotmesis demonstrate the same results. Immediately 
after axonotmesis motor conduction studies show the same pattern as neuropraxia until 
Wallerian degeneration has occurred. Typically, Wallerian degeneration occurs 9 days after 
injury, and it becomes possible to distinguish neuropraxia and axonotmesis. After this time, 
amplitude of the motor response falls and later responses are absent in both proximal and 
distal of the lesion [115]. Consequently, EMG and NCS should be used complementarily to 
define the characteristics of the injury (complete or incomplete injury, localization, injury age, 
injury grade, prognosis and postoperative recovery) [49].
Radiological studies have a limited role in diagnosing peripheral nerve injuries. However, 
they may be used complementary to the electrodiagnostic studies. Mostly magnetic reso-
nance imaging (MRI) and high-resolution ultrasound are used for peripheral neuroimaging. 
Both are helpful to determine the exact site of the lesion particularly when electrodiagnostic 
studies are insufficient [49].
9. Treatment strategies of peripheral nerve injury
The recovery time of the injured nerve depends on various external factors including most 
importantly early nerve exploration and repair. However, it should be known that axonal 
regeneration rate is as slow as 1–2 mm per day and there is no treatment to accelerate this 
process [15]. The irreversible motor unit degeneration starts 12–18 months after denervation 
of the muscle but may persist for 26 months [116]. Recovery of sensory regeneration may take 
longer. Additional injury at target muscles or an injury in peripheral supportive tissue delays 
the recovery more than usual.
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The features of the injury define the type or timing of the surgical nerve repair. There are three 
types of wound including tidy, untidy and closed traction injuries. The tidy wound may be 
made by a glass or a scalpel, which has sharp edges and primary repair is a preferable treat-
ment option. Untidy wound samples are open fractures or gunshot wounds with extensive 
tissue damage and infection and cannot be repaired immediately. Closed traction injuries 
have retracted and damaged nerves, vessels and peripheral supportive tissues. Closed trac-
tion injuries have the worst outcomes of all wounds.
Nerve exploration and repair indications are paralysis around the injured nerve, closed injury 
with supportive tissue damage, open injury requiring open reduction and internal fixation, 
nerve lesions with arterial damage, traction injuries to the brachial plexus, declining nerve 
function after diagnosis, failure of neurological improvement, failure to improve after a con-
duction block within 6 weeks of the injury and persistent pain or neuroma formation [4].
9.1. Direct nerve repair
Direct nerve repair with microsurgical techniques is still a gold-standard treatment method 
for axonotmesis and neurotmesis injuries [14]. Direct suturing repair without grafting is used 
for short nerve deficits (<5 mm). Larger deficits require nerve grafting. Repair of a large gap 
without grafting exhibits excessive tension and produce poor outcomes. In terms of recovery 
for larger gaps, repair with nerve grafting has better outcomes compared to primary repair 
without grafting [4].
9.2. Fibrin glue
Fibrin glue enables primary sutureless repair with an adhesive. Repair with fibrin sealants 
ensures shorter recovery time, less fibrosis and decreased inflammatory reactions. Studies do 
not report any difference between fibrin glue and direct suturing in terms of axonal regen-
eration, fibre alignment and nerve conduction velocity recovery [117]. The most important 
advantage of the fibrin glue is quick and easy application in emergency conditions whenever 
there is absence of experienced surgeon for nerve repair.
9.3. Nerve grafts
Autologous nerve grafts are the gold-standard option in peripheral nerve repairs. As reported 
in the literature, autologous nerve grafting has better recovery results in long nerve deficits (>3 
cm), more proximal injuries and critical nerve injuries [15]. Donor nerve grafts are extracted 
from expandable sensory nerves such as sural and medial antebrachial nerves. Autologous 
nerve grafting has best results because it has necessary materials for nerve regeneration like 
Schwann cells, basal lamina, neurotrophic factors and adhesion molecules [2]. Despite its supe-
rior results, using autologous nerve grafts has some limitations including limited tissue avail-
ability, necessity for second surgery, the graft, donor-site morbidity, loss of nerve function and 
potential difference in tissue size. Allograft nerves that are collected from a cadaver or donor 
for nerve grafting are other options. Donor allografts contain viable donor Schwann cells, and 
immunosuppressive therapy is needed for 18–24 months to inactivate these cells for sustained 
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 regeneration. Immunosuppressive therapy has many side effects including opportunistic infec-
tions and tumour formation. Cadaveric nerve allografts are used in patients who have inad-
equate autologous nerve grafts. The recovery results are good, but the process is too expensive 
and requires experience to perform [118–121].
Currently, scientists focused their research on acellular human nerve allografts with the aim 
to eliminate the need for immunosuppressants. The decellularization process is performed 
using chemical detergents, enzyme degradation or irradiation [122]. Acellular nerve grafts are 
removed from Schwann cells and myelin, but the internal neuronal structure and extracellular 
matrix (collagen, laminin and growth factors) are preserved [123]. Regeneration process with 
acellular allografts involves host's migrated Schwann cells. Thus, even when acellular nerve 
grafts show good outcomes in trials, they are still insufficient in long nerve deficit repairs. In 
future, acellular grafts supplemented with seed cells, and growth factors may improve the 
surgical repair outcomes of large gap peripheral nerve injuries [124].
9.4. Nerve conduits
In recent years, research efforts have focused on the development of conduits as an alternative 
treatment especially for larger defects. Nerve conduits serve as a bridge between the proximal 
and distal stumps of the injured nerve and provide a scaffold for axonal regeneration. The 
most important advantage of a conduit is the ability to provide an ideal microenvironment for 
neuronal recovery. For this purpose, an ideal nerve conduit should have properties like bio-
compatibility, permeability, flexibility, biodegradability, compliance, neuroinductivity and 
neuroconductivity with appropriate surface [137, 138].
Conduits are categorized into two groups according to their materials as biological and syn-
thetic conduits.
Biological nerve conduits include autologous arteries, veins, muscle, human amniotic mem-
brane and umbilical cord vessels. Major advantages of biological conduits are non-activation 
of foreign body reaction, biocompatibility and enhanced migration of supportive cells. These 
biomaterials have been widely used for repair of short gap (<3 cm) nerve injuries, and the 
outcomes were consistent with those of nerve grafts [125–127, 138].
Synthetic nerve conduits include degradable and nondegradable conduits. Nondegradable nerve 
conduit materials include silicone, elastomeric hydrogel and porous stainless steel. Reconstruction 
with these materials is successful, but the possibility of foreign body reaction, scar tissue forma-
tion secondary to inflammation, lack of stability and the inflexible structure limit extensive use of 
them. Another disadvantage is the requirement of a second surgery for conduit removal.
Commonly used degradable conduit materials include collagen, polyesters (e.g., polyglycolic 
acid (PGA)), chitosan, polylactic acid (PLA) and hydrogel. These materials induce only mini-
mal foreign body reaction, and several investigators reported effective nerve regeneration with 
these conduits [128]. Particularly, collagen conduits have shown comparable results with autol-
ogous nerve grafts in animal studies. There are many Food and Drug Administration (FDA) 
approved collagen-based conduits such as NeuraGen, NeuroFlex, NeuroMatrix, NeuroWrap 
and NeuroMend. Researchers observed that collagen conduits are resorbable, flexible, and 
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cause minimal scar formation, allow nutrient transfer and provide suitable environment for 
nerve regeneration without any compression neuropathy. Over time, the material choice for 
nerve conduits shifted towards the use of more biocompatible synthetic polymers. Examples 
of these polymers are polylactic acid (PLA), polyglycolic acid (PGA), poly-caprolactone (PCL) 
and poly-lactide caprolactone (PLCL). Neurotube is a PGA nerve conduit, and Neurolac is a 
PLCL conduit. Neurotube was designed for gaps between 8 mm and 3 cm and is resorbed 
within 6–8 months. Neurolac is available as a tube with a length of 3 cm. In clinical trials, PGA 
conduits had comparable results with gold standards in the treatment of gaps up to 20 mm. A 
human study reported fistulization and neuroma in hand nerve surgery with PLCL conduits. 
Fibrin, gelatin, keratin and silk are other biopolymer conduit materials that are still under 
experimental evaluation [137, 138].
Studies have concluded that none of the experimental materials used for nerve conduits per-
formed better than nerve grafts. However, observations showed that some of the properties 
make nerve conduits more useful (see Table 1). Conduits developed in the future should have 
a combination of aforementioned favourable properties.
9.5. Growth factors
Neurotrophic growth factors which are naturally released from injured nerves are used dur-
ing nerve repair interventions. Studies about nerve repair pathophysiology reported that these 
growth factors act as cell regulators and they are all essential. Several studies showed that all these 
neurotrophins promote peripheral nerve regeneration [132, 133]. Additionally, neurotrophic 
growth factors promote both outgrowth and survival of motor and sensory neurons. Principal 
neurotrophic factors used for peripheral nerve regeneration are presented in Table 2. In experi-
mental models, growth factors for nerve regeneration are generally used with nerve conduits.
9.6. Cell-based therapy
The limitations of present therapies are slow nerve regeneration and insufficient filling of 
large nerve gaps. To overcome these limitations, cell-based therapy was designed to provide 
supportive cells to the lesion site with the aim to accelerate nerve regeneration. Supportive 
Should not harm peripheral tissue of the injury site
Resorbable
Limiting fibrous tissue infiltration
Allowing nutrient transfer with pores
Protein release (laminin/fibronectin)
Appropriate internal diameter to allow nerve regeneration
Release of neurotrophic factors
Allowing electrical conductance
Table 1. Desired features of the nerve conduits [137].
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cell additions are combined with nerve grafts or conduits. Most extensively studied thera-
peutic models have included Schwann cells (SCs), but scientific improvements were achieved 
with different types of stem cells as well. Cell-based therapy is performed with stem cells 
owing to their self-renewal ability and capacity for differentiation into specialized cell types. 
Investigations on cell-based therapy are still in the preclinical level except some trials on 
Schwann cells [139]. Stem cells used for nerve repair interventions are mentioned in Table 3.
Schwann cells, bone marrow-derived mesenchymal stem cells (BMSCs), adipose-derived mes-
enchymal stem cells (ADSCs) and pluripotent stem cells are the primary cell types which are 
used in research studies. First of all, SCs are the most important and first-choice seed cells 
because they are the primary functional cells of the nervous system. SCs have a crucial role 
in nerve regeneration by producing neurotrophic factors such as nerve growth factor (NGF), 
brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor, platelet-derived growth 
factor and neuropeptide Y. In addition to being a supply for growth factors, SCs are capable of 
proliferation, immune modulation, remyelination and migration. All of these enhance repaired 
nerve healing. In cell-based therapies, neural crest cells are the main source of Schwann cells. 
SC seeds transplanted in a nerve conduit enhance axonal regeneration, but SC seeds have some 
disadvantages such as slow expansion to large numbers and being hard to obtain [129, 130, 140].
Neurotrophic factors Effect
Nerve growth factor (NGF) Survival signalling, neurite outgrowth
Glial cell line-derived neurotrophic factor (GDNF) Sensory regeneration
Brain-derived neurotrophic factor (BDNF) Positive modulation of peripheral nerve myelination
Neurotrophin-3 (NT-3) Negative modulation of peripheral nerve myelination
Neurotrophin-4/5 (NT-4/5) Survival of sensory neurons
Ciliary neurotrophic factors (CNTF) Survival of motor neurons
Table 2. The effects of neurotrophic factors in peripheral nerve regeneration [137].
Embryonic stem cells (ESCs)
Neural stem cells (NSCs)
Bone marrow-derived stem cells (BMSCs)
Adipose-derived stem cells (ADSCs)
Skin-derived precursor stem cells (SKP-SCs)
Foetal-derived stem cells
Hair follicle stem cells (HFSCs)
Dental pulp stem cells (DPSCs)
Muscle-derived stem/progenitor cells (MDSPCs)
Induced pluripotential stem cells (iPSCs)
Table 3. Stem cells studied in peripheral nerve repair [139].
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Embryonic stem cells (ESCs) have preferable advantages such as providing an unlim-
ited source of cells, good differentiation potential and long-lasting proliferation capacity. 
However, ethical concerns are the major problem when these cells are used for transplanta-
tion. NSCs have the ability to differentiate into neurons and glial cells, but their use is limited 
because harvesting of these cells is difficult and there is a risk for formation of neuroblastoma. 
Bone marrow-derived stem cells (BMSCs) have the potential to differentiate into SC-like 
cells (BMSC-SCs). However, studies showed that differentiation potential of BMSCs is not 
as strong as NSCs. Also, harvesting procedure is painful and results in a lower cell fraction 
compared to other stem cells. Harvesting of ADSCs is minimally invasive and results in a 
high cellular yield. ADSCs can differentiate into SC-like cells and release BDNF, NGF and 
vascular endothelial growth factor (VEGF). These factors facilitate recruitment of endogenous 
SCs. The most important factor limiting the use of ADSCs is the potential to differentiate into 
adipocytes. Studies on BMSC-SCs and ADSC-SCs have yielded promising results [131, 140].
Foetal stem cells can be derived from amniotic fluid, amniotic membrane, umbilical cord 
and Wharton’s jelly. Both amniotic tissue-derived stem cells (ATDSCs) and umbilical cord-
derived mesenchymal stem cells (UC-MSCs) have differentiation and proliferation potential. 
ATDSCs also exhibit strong angiogenic potential and cause augmented neuronal injury perfu-
sion. Tumorigenesis is one of the important side effects of UC-MSCs secondary to their high 
proliferation potential. Wharton’s Jelly MSCs show specific mesenchymal features like gener-
ating neurotrophic factors such as NGF, BDNF and NT-3. Major advantages of foetal-derived 
stem cells are easy access and less immunoreactivity. Ethical issues are the most important 
disadvantage of foetal-derived stem cells. Skin-derived precursor stem cells (SKP-SCs) are 
found in the dermis and can differentiate into many kind of cells like neurons and glial cells. 
It is reported that SKP-SCs accelerate nerve regeneration. Hair follicle stem cells (HFSCs) have 
a unique feature of differentiation into SCs directly without any genetic intervention. Animal 
studies reported improved nerve repair with HFSCs. Several drawbacks associated with the 
stem cells have led to research efforts for alternative cells like induced pluripotential stem 
cells (iPSCs). iPSCs showed enhanced neuronal regeneration, but tumorigenicity, need for 
immunosuppression and chromosomal aberrations limit their use [139, 140].
As a result, ideal cells to be used for neural regeneration should have the properties of being 
suitable for easy harvesting, not requiring immunosuppression, being able to integrate to the 
injury site and being non-tumorigenic. And the success of a cell-based therapy depends on 
the transplanted cell's ability to differentiate into Schwann-like cells, to release neurotrophic 
growth factors and to induce myelinization of axons. Schwann cell cultures have mostly 
shown acceptable results in experimental studies; however, they are not good enough and 
search for an ideal cell is still ongoing. Bone marrow-derived mesenchymal cells have also 
demonstrated favourable results with numerous advantages like easy harvesting, high cell 
viability and secretion of multiple trophic factors [139, 140].
Even though cell-based therapy is promising for future, it is already associated with certain 
limitations. The most important issue is cell transplantation safety, and the other is that cell 
preparations are time consuming. These delays might cause the most appropriate interven-
tion time for neuronal repair to be missed.
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9.7. Other methods
Freeze-thawed muscle graft, nerve transfer and direct muscular neurotization are the other 
surgical methods for nerve repair. In the nerve transfer surgery, the uninjured nerve is trans-
ferred to the distal stump of the injured nerve. During the direct muscular neurotization, the 
avulsed end of the nerve is implanted into the muscle directly. All of these techniques still 
need further improvement [133–136].
10. Conclusion
Microsurgical direct nerve repair is still gold standard for peripheral nerve repair whenever 
possible with a tension-free and early repair. It should not be forgotten that nerve repair 
that would give the optimum result requires healthy supportive tissue. If there is large 
nerve deficit, the autologous nerve graft is accepted as the gold standard. Second surgery, 
potential for neuroma formation and loss of donor nerve function are the main disadvan-
tages of autologous nerve grafting. And all these limitations cause to perform acellular 
human nerve grafts. Acellular grafts have promising results but are still insufficient for large 
nerve deficits. At this stage, nerve conduits which stand out with the formation of an ideal 
microenvironment in the large nerve defects are increasingly foreground. But performing 
successful results with nerve conduits still requires combination of pharmacological and 
molecular therapies. Researches should focus on both axonal regeneration and achieving 
optimum microenvironment. In this context, it is important to manipulate Schwann cells. 
Because SCs provide supportive cell proliferation, remyelination and growth factor supply. 
Studies about performing SCs-like cells become more important because harvesting SCs is 
not an easy and safe procedure. BMSCs and ADSCs have promising results, but tumorige-
nicity, need for immunosuppression and long-time need for cell preparations limit widely 
accepted clinical use of stem cells. Recent studies focus on manipulation of SCs to improve 
their contribution to nerve regeneration by increased motility, ability of differentiation and 
producing neurotrophic factors.
In conclusion, the combination of genetically modified Schwann like cells and conduits or 
acellularized grafts as three-dimensional structured scaffolds will finally achieve optimum 
functional recovery after peripheral nerve injury.
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